Prostate News Archive
19-Oct-2008
Surgery overpromoted in case of enlarged prostate: Study (New Kerala)
London, Oct 18 : A new study has warned that in case of enlarged prostate, new surgical procedures are being promoted without proper or adequate evaluation. Ghana: Prostate Problems in Men (AllAfrica.com)
According to the Ministry of Health, prostate cancer is amongst THE THREE biggest killers of Ghanaian men. This special report seeks to ask what prostate cancer is, its causes and what can be done to prevent the disease. Takeda, Cell Genesys End Development of Prostate-Cancer Vaccine (Bloomberg)
Oct. 17 (Bloomberg) -- Takeda Pharmaceutical Co. , Japan's largest drugmaker, and Cell Genesys Inc. will end development of the prostate-cancer vaccine GVAX after two studies failed to show the product was safe and prolonged patients' lives. Prostate Cancer: Biomarkers - Coverage From The 60th Annual Congress Of The German Urological Association (Medical News Today)
STUTTGART, GERMANY (UroToday.com) - The value of PCA3 in urine was investigated in a prospective European trial on 463 patients who had previously undergone one or two negative prostate biopsies and who were scheduled for a re-biopsy of their prostate. In 128 patients prostate cancer was found on re-biopsy. The area under the curve was 0.658 for PCA3 compared to 0.578 for free PSA.
Back to Prostate News Archive
